Antibodies and kits for the pathology department

Ended Awarded Last action

Contract number
HT001420F0023
Awardee
Awarding agency
Obligated
$78,883

Award facts

Contract value 100% obligated
$78,882.58 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$46,117
Original award $125,000

About this award

This firm fixed price blanket purchase agreement (BPA) call contract was awarded by the Defense Health Agency to Cell Marque Corporation on November 6, 2019 for the delivery of antibodies and kits for the agency's Pathology Department. With a potential value of $78,882.58, the contract has a completion date of November 5, 2020 and does not have a set-aside designation. Cell Marque Corporation will deliver the requested products from their facility located in Bethesda, Maryland to support the Defense Health Agency's medical laboratory testing programs. No major subcontractors were identified.

Quick answers

Who was awarded contract HT001420F0023?

HT001420F0023 was awarded to Cell Marque Corp by Defense Health Agency (Department of Defense) on November 6, 2019.

How much is contract HT001420F0023 worth?

The government has obligated $78,883 on HT001420F0023.

Is contract HT001420F0023 an order under another contract?

Yes. HT001420F0023 is a BPA call under HT001419A0035, a blanket purchase agreement.

Was contract HT001420F0023 competed?

The extent of competition for HT001420F0023 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award